Nanologica
13 SEK 0 %Vær den første som følger denne virksomhed
Nanologica is a biotechnology company that develops, manufactures, and sells nanoporous silica particles for life science applications. The company has two business areas: chromatography which is an analysis and purification technique in the pharmaceutical industry where the company's products are used in the purification of, for example, insulin, and drug development where the company develops an inhalation platform to deliver drugs locally in the lung. Nanologica was founded in 2004 and is headquartered in Södertälje.
Læs mereOmsætning
1,56 mio.
EBIT %
-3.259,62 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
NICA
Daglig lav / høj pris
12,8 / 13
SEK
Markedsværdi
366,16 mio. SEK
Aktieomsætning
60,14 t SEK
Volumen
4,6 t
Finanskalender
Delårsrapport
07.07.2023
Delårsrapport
27.10.2023
Viser Alle indholdstyper